HAYA Therapeutics seeks an accomplished and strategic Vice President of Business Development to join our dynamic team. You will be critical in driving HAYA's growth strategy, identifying and evaluating new business opportunities, and forming strategic partnerships. To excel in this role, you need deep biotech/pharma industry knowledge, a strong scientific background, and excellent interpersonal skills.
Main Responsibilities: Develop and execute HAYA's business development strategy, which reflects the company's mission and objectives.Identify, evaluate, and pursue strategic partnership opportunities, including licensing deals, collaborations, and M&A prospects.Negotiate on behalf of the company for complex business transactions and provide oversight during the due diligence process.Cultivate relationships with major stakeholders within the biotech/pharma sector, including potential partners, investors, and thought leaders.Work closely with HAYA's science team to understand the company's technology platform and pipeline to be able to turn scientific advances into meaningful business opportunities.Team up with R&D, clinical, legal, finance, and other departments on cross-functional projects that support business development initiatives.Keep up to date with industry trends, the competitive landscape, and emerging technologies applicable to the areas of focus at HAYA.Represent HAYA at industry conferences and other events to enhance the company's visibility and network.Qualifications: Advanced degree in life sciences (preferably PhD or MD) with MBA or equivalent business experience.15+ years' experience in business development, licensing, or corporate strategy within the biotech/pharma industry.Demonstrated record of successfully closing major deals and strategic partnerships.Broad understanding of the drug discovery and development process, particularly in RNA therapeutics.Strong analytical and financial skills for modeling.Strong leadership skills, including excellent communication and presentation capabilities.Able to thrive under pressure in an environment full of fast-moving change.On average, candidates must be ready to travel as often as 20-30%.
The Company: HAYA Therapeutics SA is a precision therapeutics company focused on discovering and developing innovative genomic medicines for fibrotic diseases and age-related health conditions, including cancer. Our discovery engine targets long non-coding RNAs (lncRNAs) within the "dark matter" of the human genome to identify novel targets and drug candidates. Our lead therapeutic candidate, HTX-001, is currently progressing through pre-clinical development.
Headquartered in Epalinges, Switzerland, HAYA is a rapidly growing company led by a world-class team and supported by a strong investor consortium.
#J-18808-Ljbffr